Published in Chem Sci on November 10, 2015
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer (2005) 13.49
The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis (2008) 9.57
A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature (2003) 6.06
Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev (2009) 5.76
Biofilm formation by Pseudomonas aeruginosa wild type, flagella and type IV pili mutants. Mol Microbiol (2003) 5.31
Persister cells and tolerance to antimicrobials. FEMS Microbiol Lett (2004) 5.23
Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents (2010) 5.18
The application of biofilm science to the study and control of chronic bacterial infections. J Clin Invest (2003) 3.46
"NONOates" (1-substituted diazen-1-ium-1,2-diolates) as nitric oxide donors: convenient nitric oxide dosage forms. Methods Enzymol (1996) 3.34
Complexes of .NO with nucleophiles as agents for the controlled biological release of nitric oxide. Vasorelaxant effects. J Med Chem (1991) 3.27
The 'right' size in nanobiotechnology. Nat Biotechnol (2003) 3.27
Reducing implant-related infections: active release strategies. Chem Soc Rev (2006) 3.09
Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J Bacteriol (2006) 2.97
Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol (2003) 2.68
Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr Pulmonol (2009) 2.53
Testing the susceptibility of bacteria in biofilms to antibacterial agents. Antimicrob Agents Chemother (1990) 2.51
Should we stay or should we go: mechanisms and ecological consequences for biofilm dispersal. Nat Rev Microbiol (2011) 2.45
Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationary-phase sigma factor expression. Appl Environ Microbiol (2002) 2.19
Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. J Clin Microbiol (2004) 1.91
Depth penetration and detection of pH gradients in biofilms by two-photon excitation microscopy. Appl Environ Microbiol (1999) 1.80
Nitric oxide signaling in Pseudomonas aeruginosa biofilms mediates phosphodiesterase activity, decreased cyclic di-GMP levels, and enhanced dispersal. J Bacteriol (2009) 1.78
Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science (1985) 1.74
Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl (2014) 1.62
Increased antibiotic resistance of Escherichia coli in mature biofilms. Appl Environ Microbiol (2009) 1.60
Bactericidal efficacy of nitric oxide-releasing silica nanoparticles. ACS Nano (2008) 1.54
Nitric oxide release: part II. Therapeutic applications. Chem Soc Rev (2012) 1.51
In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections. J Bacteriol (2007) 1.46
The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol (2012) 1.26
Nitric oxide release: part I. Macromolecular scaffolds. Chem Soc Rev (2012) 1.26
Preparation and characterization of hydrophobic polymeric films that are thromboresistant via nitric oxide release. Biomaterials (2000) 1.23
Nitric oxide release: part III. Measurement and reporting. Chem Soc Rev (2012) 1.23
Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirin. Proc Natl Acad Sci U S A (2006) 1.20
Dispersed cells represent a distinct stage in the transition from bacterial biofilm to planktonic lifestyles. Nat Commun (2014) 1.20
Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev (2014) 1.16
Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances. ACS Chem Biol (2011) 1.12
Nitric oxide-releasing fumed silica particles: synthesis, characterization, and biomedical application. J Am Chem Soc (2003) 1.08
Comparative effects of several nitric oxide donors on intracellular cyclic GMP levels in bovine chromaffin cells: correlation with nitric oxide production. Br J Pharmacol (1999) 1.08
Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation. Biomaterials (2000) 1.08
Incidence and clinical implication of nosocomial infections associated with implantable biomaterials - catheters, ventilator-associated pneumonia, urinary tract infections. GMS Krankenhhyg Interdiszip (2011) 1.06
Nitric oxide regulation of cyclic di-GMP synthesis and hydrolysis in Shewanella woodyi. Biochemistry (2012) 1.06
Influence of scaffold size on bactericidal activity of nitric oxide-releasing silica nanoparticles. ACS Nano (2011) 1.05
Clearance of Pseudomonas aeruginosa foreign-body biofilm infections through reduction of the cyclic Di-GMP level in the bacteria. Infect Immun (2013) 1.04
Inaccuracies of nitric oxide measurement methods in biological media. Anal Chem (2013) 0.98
Novel therapeutic applications of nitric oxide donors in cancer: roles in chemo- and immunosensitization to apoptosis and inhibition of metastases. Nitric Oxide (2008) 0.96
Temperature and pH affect the production of bacterial biofilm. Folia Microbiol (Praha) (2010) 0.94
Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles. ACS Appl Mater Interfaces (2013) 0.94
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine (2012) 0.93
Nitric oxide: a key mediator of biofilm dispersal with applications in infectious diseases. Curr Pharm Des (2015) 0.93
Controlled nitric oxide delivery platform based on S-nitrosothiol conjugated interpolymer complexes for diabetic wound healing. Mol Pharm (2010) 0.92
Nitric oxide-releasing quaternary ammonium-modified poly(amidoamine) dendrimers as dual action antibacterial agents. Bioconjug Chem (2014) 0.91
Shape- and nitric oxide flux-dependent bactericidal activity of nitric oxide-releasing silica nanorods. Small (2013) 0.90
Nitric oxide-releasing chitosan oligosaccharides as antibacterial agents. Biomaterials (2013) 0.88
Antimicrobial GL13K peptide coatings killed and ruptured the wall of Streptococcus gordonii and prevented formation and growth of biofilms. PLoS One (2014) 0.87
Cephalosporin-3'-diazeniumdiolates: targeted NO-donor prodrugs for dispersing bacterial biofilms. Angew Chem Int Ed Engl (2012) 0.86
Nitric oxide-releasing amphiphilic poly(amidoamine) (PAMAM) dendrimers as antibacterial agents. Biomacromolecules (2013) 0.86
Dynamic-covalent macromolecular stars with boronic ester linkages. J Am Chem Soc (2011) 0.86
Polynitrosated polyesters: preparation, characterization, and potential use for topical nitric oxide release. Biomacromolecules (2005) 0.85
Anti-Biofilm Efficacy of Dual-Action Nitric Oxide-Releasing Alkyl Chain Modified Poly(amidoamine) Dendrimers. Mol Pharm (2015) 0.84
Fabrication and characterization of a nitric oxide-releasing nanofibrous gelatin matrix. Biomacromolecules (2013) 0.83
Light-triggered eradication of Acinetobacter baumannii by means of NO delivery from a porous material with an entrapped metal nitrosyl. J Am Chem Soc (2012) 0.83
Synthesis of cephalosporin-3'-diazeniumdiolates: biofilm dispersing NO-donor prodrugs activated by β-lactamase. Chem Commun (Camb) (2013) 0.82
Multi-arm polymeric nanocarrier as a nitric oxide delivery platform for chemotherapy of head and neck squamous cell carcinoma. Biomaterials (2012) 0.81
Nitric Oxide Regulation of Bacterial Biofilms. Biochemistry (2015) 0.80
Nanoparticle (star polymer) delivery of nitric oxide effectively negates Pseudomonas aeruginosa biofilm formation. Biomacromolecules (2014) 0.79
Accurate nitric oxide measurements from donors in cell media: identification of scavenging agents. Anal Chem (2014) 0.78
Intracellular nitric oxide delivery from stable NO-polymeric nanoparticle carriers. Chem Commun (Camb) (2012) 0.78
Synthesis of functional core, star polymers via RAFT polymerization for drug delivery applications. Macromol Rapid Commun (2012) 0.77
S-Nitrosothiol-modified nitric oxide-releasing chitosan oligosaccharides as antibacterial agents. Acta Biomater (2014) 0.77
pH triggered self-assembly of core cross-linked star polymers possessing thermoresponsive cores. Chem Commun (Camb) (2011) 0.77
Synthesis and characterization of a multi-arm poly(acrylic acid) star polymer for application in sustained delivery of cisplatin and a nitric oxide prodrug. J Polym Sci A Polym Chem (2012) 0.77
Nanoparticles based on star polymers as theranostic vectors: endosomal-triggered drug release combined with MRI sensitivity. Adv Healthc Mater (2014) 0.76
Bimolecular control over polypropene stereochemical microstructure in a well-defined two-state system and a new fundamental form: stereogradient polypropene. Angew Chem Int Ed Engl (2006) 0.76
Design, synthesis, and evaluation of fimbrolide-nitric oxide donor hybrids as antimicrobial agents. J Med Chem (2013) 0.75
Targeted release of tobramycin from a pH-responsive grafted bilayer challenged with S. aureus. Biomacromolecules (2015) 0.75
Probing the internal micromechanical properties of Pseudomonas aeruginosa biofilms by Brillouin imaging. NPJ Biofilms Microbiomes (2017) 0.75